[Preoperative chemotherapy in head-neck tumors. Chances and risks of this therapeutic procedure].
We submit our present work dealing with stage III and IV squamous cell carcinomas of the head and neck referred for preoperative chemotherapy. Our results are based on a histological serial section investigation of the tumour tissues. In at least 50% inadequate tumour resection was observed with a tendency to increase if preoperative chemotherapy was conducted.
Klima
A
A
Hals-Nasen-Ohren-Universitätsklinik der Johann-Wolfgang-Goethe- Universität, Frankfurt/Main.
Bettinger
R
R
Desloovere
C
C
Knecht
R
R
D001761:Bleomycin / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D006801:Humans; D007012:Hypopharyngeal Neoplasms / Q000188:drug therapy; D009062:Mouth Neoplasms / Q000188:drug therapy; D037981:Neck Dissection; D009959:Oropharyngeal Neoplasms / Q000188:drug therapy; D011446:Prospective Studies; D012307:Risk Factors
D001761:Bleomycin; D002945:Cisplatin
Pröperative Chemotherapie bei Kopf-Hals-Tumoren. Chancen und Risiken dieses therapeutischen Vorgehens.